What's breaking now, across thousands of outlets.
If you don't fully understand how the program works, you could be in for a major blow.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
For women experiencing recurrent pregnancy loss or difficulty conceiving, prolactin testing is a reasonable part of a comprehensive hormonal evaluation.
Saudi Health Ministry begins offering the seasonal influenza vaccine and notes most ICU flu cases last year were unvaccinated.
Skyhawk Therapeutics’ RNA-splicing candidate for Huntington’s disease improved patients’ symptoms in an early stage-trial, the company said, as it moves to pivotal development.
<p>Sydney, Australia: Losing muscle mass as people age could be an important warning sign for dementia risk, new Australian-led research has found.</p> <p>Researchers analyzed more than 80 studies…
Investors are pumping $123 million into a tiny Michigan biotech that is resurrecting an Astellas cancer drug for an eye disease that has attracted lots of VC and pharma attention in recent years.
